Meeder Advisory Services’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
Meeder Advisory Services's IONS Position: Q2 2026 in Review
Meeder Advisory Services increased its Ionis Pharmaceuticals (IONS) stake by 5.8% in Q2 2026, buying an estimated $31.7K and bringing the position to 7,660 shares worth $607K. The position accounts for 0.02% of the portfolio, ranked #385.
Meeder Advisory Services first reported a position in IONS in Q2 2025 and has held it in 5 quarters since. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.
- Meeder Advisory Services held 7,660 shares of Ionis Pharmaceuticals worth $607K as of Q2 2026.
- Meeder Advisory Services bought 421 Ionis Pharmaceuticals shares in Q2 2026, an estimated $31.7K.
- Ionis Pharmaceuticals made up 0.02% of Meeder Advisory Services's portfolio in Q2 2026, its #385 holding.
- Meeder Advisory Services first reported a position in Ionis Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
- 515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.
Based on Meeder Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.